Inventors:
Peter Bugelski - Drexel Hill PA, US
Charles Davis - Devon PA, US
Brian MacDonald - Valley Forge PA, US
Assignee:
SmithKline Beecham Corporation
International Classification:
A61K038/16, A61K039/395
Abstract:
An improved method of treating immune cell mediated systemic diseases, particularly T and B cell mediated diseases, is provided by increasing the systemic exposure, or bioavailibility, of a therapeutic protein. Such therapeutic protein is selected from the group consisting of a monoclonal antibody, a soluble receptor and a soluble ligand which binds to an antigen expressed on the surface of an immunce cell.